Amgen expects approval for Xgeva as bone treatment in April
Thousand Oaks-based Amgen said Aug. 22 that the U.S. Food and Drug Administration will likely make a decision by April 26, 2012 on the biotech firm’s application to expand the use of its Xgeva bone treatment drug to treat advanced prostate cancer. Amgen, the largest biotech company in the world, said in a statement that Read More →
10-K report: Vitesse looks for profitability
In the space of a decade, Vitesse Semiconductor Corp. fell from the throne of a blue-chip stock to a largely unprofitable player in the communications industry.
Maguire teams up with Florida firm
Maguire Investments of Santa Maria has joined forces with JHS Capital Advisors, a Florida-based asset management firm.
Yardi buys insurance firm
Real estate software firm Yardi Systems said Aug. 16 that it has purchased Dallas-based Multifamily Insurance Group.
Interlink earnings down 47%
Sensor technology company Interlink Electronics earned $718,000 in the second quarter, down 46.9 percent from $1.4 million a year ago.
NiMin reports $3.8M profit
NiMin Energy Corp. earned $3.8 million, or 6 cents per share, in the second quarter of the year, swinging back to black after a $2.5 million loss in the same period a year ago.
Banks map out growth plans
Three recent earnings reports from area banks shed light on the tri-county economy as we approach the three-year anniversary of the crisis that nearly wrecked the nation’s financial system.
